Evidence to support use of palonosetron over generic serotonin type 3-receptor antagonists for chemotherapy-induced nausea and vomiting

Am J Health Syst Pharm. 2014 Mar 15;71(6):500-6. doi: 10.2146/ajhp130394.
No abstract available

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects*
  • Clinical Trials as Topic / methods
  • Drugs, Generic / therapeutic use
  • Evidence-Based Medicine* / methods
  • Humans
  • Isoquinolines / therapeutic use*
  • Nausea / chemically induced
  • Nausea / drug therapy*
  • Palonosetron
  • Quinuclidines / therapeutic use*
  • Serotonin 5-HT3 Receptor Antagonists / therapeutic use*
  • Vomiting / chemically induced
  • Vomiting / drug therapy*

Substances

  • Antineoplastic Agents
  • Drugs, Generic
  • Isoquinolines
  • Quinuclidines
  • Serotonin 5-HT3 Receptor Antagonists
  • Palonosetron